|
1
|
Pandya RS, Mao L, Zhou H, Zhou S, Zeng J,
Popp AJ and Wang X: Central nervous system agents for ischemic
stroke: Neuroprotection mechanisms. Cent Nerv Syst Agents Med Chem.
11:81–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jhelum P, Karisetty BC, Kumar A and
Chakravarty S: Implications of epigenetic mechanisms and their
targets in cerebral ischemia models. Curr Neuropharmacol.
15:815–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang YF, Liu ZQ, Cui W, Zhang WT, Gong
JP, Wang XM, Zhang Y and Yang MJ: Antioxidant effect of salvianolic
acid B on hippocampal CA1 neurons in mice with cerebral ischemia
and reperfusion injury. Chin J Integr Med. 21:516–522. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen H, Yoshioka H, Kim GS, Jung JE, Okami
N, Sakata H, Maier CM, Narasimhan P, Goeders CE and Chan PH:
Oxidative stress in ischemic brain damage: Mechanisms of cell death
and potential molecular targets for neuroprotection. Antioxid Redox
Signal. 14:1505–1517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma MW, Wang J, Zhang Q, Wang R, Dhandapani
KM, Vadlamudi RK and Brann DW: NADPH oxidase in brain injury and
neurodegenerative disorders. Mol Neurodegener. 12:72017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang HF, Li TB, Liu B, Lou Z, Zhang JJ,
Peng JJ, Zhang XJ, Ma QL, Peng J and Luo XJ: Inhibition of myosin
light chain kinase reduces NADPH oxidase-mediated oxidative injury
in rat brain following cerebral ischemia/reperfusion. Naunyn
Schmiedebergs Arch Pharmacol. 388:953–963. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang YS, Liu B, Luo XJ, Li TB, Zhang JJ,
Peng JJ, Zhang XJ, Ma QL, Hu CP, Li YJ, et al: Nuclear cardiac
myosin light chain 2 modulates NADPH oxidase 2 expression in
myocardium: A novel function beyond muscle contraction. Basic Res
Cardiol. 110:382015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katz LH, Li Y, Chen JS, Muñoz NM, Majumdar
A, Chen J and Mishra L: Targeting TGF-β signaling in cancer. Expert
Opin Ther Targets. 17:743–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hata A and Chen YG: TGF-β signaling from
receptors to Smads. Cold Spring Harb Perspect Biol. 8:a0220612016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gomes FC, Vde Sousa O and Romão L:
Emerging roles for TGF-beta1 in nervous system development. Int J
Dev Neurosci. 23:413–424. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vivien D and Ali C: Transforming growth
factor-β signalling in brain disorders. Cytokine Growth Factor Rev.
17:121–128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Docagne F, Ali C, Lesne S, Nicole O,
MacKenzie ET, Buisson A and Vivien D: Does transforming growth
factor-beta (TGF-beta) act as a neuroprotective agent in cerebral
ischemia? J Soc Biol. 197:145–150. 2003.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hagler MA, Hadley TM, Zhang H, Mehra K,
Roos CM, Schaff HV, Suri RM and Miller JD: TGF-β signalling and
reactive oxygen species drive fibrosis and matrix remodelling in
myxomatous mitral valves. Cardiovasc Res. 99:175–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clark JD, Gebhart GF, Gonder JC, Keeling
ME and Kohn DF: Special report: The 1996 guide for the care and use
of laboratory animals. ILAR J. 38:41–48. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belarbi K, Cuvelier E, Destée A, Gressier
B and Chartier-Harlin MC: NADPH oxidases in Parkinson's disease: A
systematic review. Mol Neurodegener. 12:842017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang ZB, Tan B, Li TB, Lou Z, Jiang JL,
Zhou YJ, Yang J, Luo XJ and Peng J: Protective effect of vitexin
compound B-1 against hypoxia/reoxygenation-induced injury in
differentiated PC12 cells via NADPH oxidase inhibition. Naunyn
Schmiedebergs Arch Pharmacol. 387:861–871. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo C, Sun L, Chen X and Zhang D:
Oxidative stress, mitochondrial damage and neurodegenerative
diseases. Neural Regen Res. 8:2003–2014. 2013.PubMed/NCBI
|
|
20
|
Grivennikova VG and Vinogradov AD:
Partitioning of superoxide and hydrogen peroxide production by
mitochondrial respiratory complex I. Biochim Biophys. 1827:446–454.
2013. View Article : Google Scholar
|
|
21
|
Di Meo S, Reed TT, Venditti P and Victor
VM: Role of ROS and RNS Sources in Physiological and Pathological
Conditions. Oxid Med Cell Longev. 2016:12450492016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kleinschnitz C, Grund H, Wingler K,
Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft
P, et al: Post-stroke inhibition of induced NADPH oxidase type 4
prevents oxidative stress and neurodegeneration. PLoS Biol.
8:e10004792010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Manea SA, Constantin A, Manda G, Sasson S
and Manea A: Regulation of Nox enzymes expression in vascular
pathophysiology: Focusing on transcription factors and epigenetic
mechanisms. Redox Biol. 5:358–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghatak S, Hascall VC, Markwald RR,
Feghali-Bostwick C, Artlett CM, Gooz M, Bogatkevich GS,
Atanelishvili I, Silver RM, Wood J, et al: Transforming growth
factor β1 (TGFβ-1)-induced CD44V6-NOX4 signaling in pathogenesis of
idiopathic pulmonary fibrosis. J Biol Chem. 292:10490–10519. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsieh HL, Wang HH, Wu WB, Chu PJ and Yang
CM: Transforming growth factor-β1 induces matrix
metalloproteinase-9 and cell migration in astrocytes: Roles of
ROS-dependent ERK-and JNK-NF-κB pathways. J Neuroinflammation.
7:882010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen CH, Ferreira JC, Gross ER and
Mochly-Rosen D: Targeting aldehyde dehydrogenase 2: New therapeutic
opportunities. Physiol Rev. 94:1–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Glatt H, Rost K, Frank H, Seidel A and
Kollock R: Detoxification of promutagenic aldehydes derived from
methylpyrenes by human aldehyde dehydrogenases ALDH2 and ALDH3A1.
Arch Biochem Biophys. 477:196–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rey FE, Cifuentes ME, Kiarash A, Quinn MT
and Pagano PJ: Novel competitive inhibitor of NAD(P)H oxidase
assembly attenuates vascular O(2)(−) and systolic blood pressure in
mice. Circ Res. 89:408–414. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen H, Song YS and Chan PH: Inhibition of
NADPH oxidase is neuroprotective after ischemia-reperfusion. J
Cereb Blood Flow Metab. 29:1262–1272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Simonyi A, Serfozo P, Lehmidi TM, Cui J,
Gu Z, Lubahn DB, Sun AY and Sun GY: The neuroprotective effects of
apocynin. Front Biosci (Elite Ed). 4:2183–2193. 2012. View Article : Google Scholar : PubMed/NCBI
|
